From Prescription to Transcription: Genome Sequence as Drug Target.

Published

Journal Article

Personalizing treatments to account for genetically mediated differences in drug responses is an exciting opportunity to improve patient outcomes. In this issue, Soccio et al. reveal new mechanisms by which non-coding variants alter the activity of the anti-diabetic drug rosiglitazone.

Full Text

Duke Authors

Cited Authors

  • Guo, C; D'Ippolito, AM; Reddy, TE

Published Date

  • July 2, 2015

Published In

Volume / Issue

  • 162 / 1

Start / End Page

  • 16 - 17

PubMed ID

  • 26140587

Pubmed Central ID

  • 26140587

Electronic International Standard Serial Number (EISSN)

  • 1097-4172

Digital Object Identifier (DOI)

  • 10.1016/j.cell.2015.06.033

Language

  • eng

Conference Location

  • United States